Media
Centre

  • Follow Us:

If you are a member of the press, please contact:

GSK Media Relations 
+ 44 (0)20 8047 5502

Learn about our newest innovative technologies and find out who to contact with media requests.

June 3, 2013

RENAISSANCE and GLAXOSMITHKLINE AGREE TO A TRANSFER OF NINE PRODUCTS

View Press Release

March 4, 2013

Regulatory Update – Stiefel, a GSK company announces a new, alternate, fixed-dose combination of Duac® (clindamycin 1% and benzoyl peroxide 3%) gains positive recommendation for approval in EuropeView Press Release

October 15, 2012

GSK Announces that Stiefel Plant in Sligo will Remain OpenView Press Release

September 27, 2012

Stiefel receives US FDA approval of Sorilux™ Foam, 0.005% for topical treatment of plaque psoriasis of the scalpView Press Release

June 11, 2012

Stiefel signs worldwide acquisition and license agreement for Toctino®View Press Release

May 30, 2012

Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitisView Press Release

May 11, 2012

Stiefel receives US FDA approval of Fabior™ Foam, 0.1%View Press Release

March 16, 2012

Stiefel and ILDS Announce Completion of First Year of Hats on for Skin Health CampaignView Press Release

November 8, 2011

New Anti-Aging Treatment Provides Increased Hydration and Skin Firmness for Consumers of All Ages.View Press Release

August 3, 2011

Regulatory update – Stiefel, A GSK company, files NDA for tazarotene foam.View Press Release